1 μg/lane of Recombinant Human Galectin-9 was resolved with SDS-PAGE under reducing (R) conditions and visualized by silver staining, showing a single band at 34 kDa.
Recombinant Human Galectin-9 (Catalog # 2045-GA) induces apoptosis of the Jurkat human acute T cell leukemia cell line. The ED50 for this effect is 1-5 μg/mL.
Measured by its ability to induce apoptosis of Jurkat human acute T cell leukemia cells. Lu, L.H. et al. (2007) J. Biochem. 141:157. The ED50 for this effect is 1-5 μg/mL. Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human Galectin-9 at 500 ng/mL can bind
Recombinant
Human TIM-3 Fc Chimera (Catalog # 2365-TM)
with an apparent Kd <30 nM.
Source
E. coli-derived human Galectin-9 protein Ala2-Thr323
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Note
<1.0 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Bioactivity
Bioactivity2
Theoretical MW
35.8 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
34 kDa, reducing conditions
Publications
Read Publications using 2045-GA in the following applications:
12 months from date of receipt, ≤ -20 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
3 months, ≤ -20 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in MOPS, NaCl, EDTA, DTT and Trehalose.
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Reconstitution Instructions
Reconstitute at 100 μg/mL in water.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human Galectin-9 Protein, CF
Ecalectin
GAL9
gal-9
galectin 9
Galectin9
Galectin-9
HUAT
lectin, galactoside-binding, soluble, 9
LGALS9
LGALS9A
MGC117375
MGC125973
MGC125974
Tumor antigen HOM-HD-21
urate transporter/channel protein
Background
Galectins comprise a family of multifunctional carbohydrate-binding proteins with specificity for N‑acetyl-lactosamine-containing glycoproteins. At least 14 mammalian Galectins share structural similarities in their carbohydrate recognition domains (CRD), forming three groups: prototype (one CRD), tandem-repeat (two CRDs), and chimeric (one CRD, unique N‑terminus) (1, 2). Full length Galectin-9 is a widely expressed 39 kDa tandem-repeat Galectin that contains two CRDs connected by a linker region (3). Progressive deletion within the linker region generates a 36 kDa isoform, also known as Ecalectin or UAT, as well as a 35 kDa isoform (4). This recombinant protein corresponds to the Ecalectin isoform of human Galectin-9 and shares 70% and 73% aa sequence identity with the corresponding regions of mouse and rat Galectin-9, respectively. Galectin-9 exhibits a wide range of activities. All three isoforms function as eosinophil chemoattractants (5, 6). This activity is destroyed by thrombin-mediated cleavage within the linker region of the long isoform, although the Ecalectin isoform is resistant to thrombin (7). Galectin-9 binds to carbohydrate moieties of IgE, thereby preventing immune complex formation, mast cell degranulation, and asthmatic and cutaneous anaphylaxis reactions (8). Independent of its lectin properties, Galectin-9 induces the maturation of dendritic cells which promote Th1 polarization (9). Galectin-9 induces cellular apoptosis in part by direct binding to TIM-3 (10, 11). Its interaction with TIM-3 inhibits Th1 cell and CD8+ cytotoxic T cell responses and also promotes regulatory T cell differentiation and activity (11, 12). Galectin-9 suppresses tumor cell metastasis by interfering with the associations between hyaluronic acid and CD44 and between VCAM-1 and Integrin alpha 4 beta 1 (13). The Ecalectin isoform (UAT; urate transporter) can also be expressed as an integral membrane protein and mediate the cellular efflux of urate (14).
Yang, R-Y. et al. (2008) Expert Rev. Mol. Med. 10:e17.
Elola, M. T. et al. (2007) Cell. Mol. Life Sci. 64:1679.
Tureci, O. et al. (1997) J. Biol. Chem. 272:6416.
Chabot, S. et al. (2002) Glycobiology 12:111.
Matsumoto, R. et al. (2002) J. Immunol. 168:1961.
Sato, M. et al. (2002) Glycobiology 12:191.
Nishi, N. et al. (2006) Glycobiology 16:15C.
Niki, T. et al. (2009) J. Biol. Chem. 284:32344.
Dai, S.-Y. et al. (2005) J. Immunol. 175:2974.
Seki, M. et al. (2007) Arthritis Rheum. 56:3968.
Zhu, C. et al. (2005) Nat. Immunol. 6:1245.
Sehrawat, S. et al. (2010) PloS Pathogens 6:e1000882.
Nobumoto, A. et al. (2008) Glycobiology 18:735.
Leal-Pinto, E. et al. (2002) Am. J. Physiol. Renal Physiol. 283:F150.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human Galectin-9 Protein, CF and receive a gift card or discount.